Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jeannette Lee

Concepts (472)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
22
2023
402
2.860
Why?
Anus Neoplasms
10
2023
26
1.960
Why?
Stroke
8
2024
520
1.800
Why?
Acquired Immunodeficiency Syndrome
11
2022
53
1.470
Why?
Prostatic Hyperplasia
10
2015
39
1.330
Why?
Brain
10
2024
1353
1.300
Why?
Parkinson Disease
2
2023
156
1.160
Why?
Chlamydia Infections
8
2017
75
1.120
Why?
Randomized Controlled Trials as Topic
8
2024
630
1.120
Why?
Papillomavirus Infections
6
2022
177
1.060
Why?
Mesenchymal Stem Cell Transplantation
2
2024
24
1.000
Why?
Sarcoma, Kaposi
12
2022
77
0.970
Why?
Chlamydia trachomatis
6
2017
29
0.940
Why?
Lymphoma, AIDS-Related
10
2020
16
0.910
Why?
Brain Ischemia
2
2023
162
0.830
Why?
Humans
104
2026
53246
0.820
Why?
Plant Extracts
5
2013
200
0.820
Why?
Serenoa
5
2013
7
0.790
Why?
Phytotherapy
3
2012
45
0.730
Why?
Rural Population
4
2023
597
0.730
Why?
Umbilical Cord
2
2020
36
0.720
Why?
Antineoplastic Combined Chemotherapy Protocols
12
2021
1043
0.660
Why?
Lymphoma, Non-Hodgkin
6
2021
58
0.660
Why?
Middle Aged
50
2021
13422
0.650
Why?
Research Design
5
2022
373
0.630
Why?
Neonatal Abstinence Syndrome
3
2024
28
0.600
Why?
Male
59
2024
27444
0.600
Why?
Adult
50
2022
14541
0.590
Why?
Fetal Blood
2
2019
79
0.590
Why?
Inflammation
3
2021
653
0.570
Why?
Rats
9
2024
3164
0.550
Why?
Patient Participation
1
2018
72
0.540
Why?
Vaginosis, Bacterial
2
2015
8
0.510
Why?
Decision Making
1
2018
278
0.480
Why?
Antineoplastic Agents
10
2023
1232
0.480
Why?
Neoplasms
3
2023
1335
0.470
Why?
Mammography
1
2016
99
0.470
Why?
Stem Cells
3
2025
189
0.460
Why?
Female
47
2024
28792
0.450
Why?
Antibodies, Monoclonal, Murine-Derived
6
2015
46
0.440
Why?
Aged
28
2020
10430
0.440
Why?
Infarction, Middle Cerebral Artery
3
2024
41
0.430
Why?
Population Density
1
2014
17
0.430
Why?
Pelvic Inflammatory Disease
2
2018
8
0.430
Why?
AIDS-Related Opportunistic Infections
5
2016
38
0.420
Why?
Animals
15
2026
13528
0.420
Why?
Stem Cell Transplantation
4
2025
191
0.420
Why?
Carcinoma in Situ
3
2013
72
0.410
Why?
Cytokines
5
2023
627
0.410
Why?
Uterine Cervicitis
1
2013
3
0.390
Why?
Anti-Bacterial Agents
5
2020
832
0.390
Why?
Urethritis
2
2012
5
0.380
Why?
Hydrocephalus, Normal Pressure
1
2012
2
0.380
Why?
Lymphoma, Large B-Cell, Diffuse
3
2021
110
0.370
Why?
Finasteride
4
2015
4
0.370
Why?
Research Subjects
1
2013
53
0.360
Why?
Guideline Adherence
1
2013
143
0.360
Why?
Breast Neoplasms
3
2017
1223
0.360
Why?
Rats, Sprague-Dawley
5
2024
1544
0.360
Why?
Subarachnoid Hemorrhage
1
2012
57
0.360
Why?
Patient Dropouts
1
2012
52
0.350
Why?
Carcinoma, Non-Small-Cell Lung
1
2013
175
0.340
Why?
Urologic Diseases
1
2011
9
0.340
Why?
Homosexuality, Male
4
2022
54
0.340
Why?
HIV-1
6
2020
60
0.330
Why?
Analgesics, Opioid
4
2024
622
0.330
Why?
Lung Neoplasms
2
2013
645
0.320
Why?
Disease Models, Animal
5
2024
1517
0.320
Why?
Mitochondria
3
2026
447
0.310
Why?
Young Adult
17
2019
4514
0.310
Why?
Papillomaviridae
3
2019
104
0.310
Why?
United States
10
2023
5413
0.310
Why?
Quality of Life
6
2024
902
0.300
Why?
Patient Selection
1
2011
273
0.300
Why?
Lymphedema
2
2022
48
0.290
Why?
HIV Seropositivity
3
2021
28
0.290
Why?
Lower Urinary Tract Symptoms
3
2013
7
0.290
Why?
Intestinal Mucosa
2
2021
229
0.290
Why?
Asthma
2
2024
319
0.290
Why?
Polymorphism, Single Nucleotide
3
2017
505
0.280
Why?
Gonorrhea
2
2020
9
0.270
Why?
Uterine Cervical Neoplasms
2
2022
301
0.270
Why?
Azithromycin
4
2020
25
0.270
Why?
Anal Canal
4
2023
27
0.260
Why?
Prospective Studies
12
2022
2412
0.250
Why?
Risk Factors
8
2022
4018
0.250
Why?
Th1 Cells
2
2017
50
0.250
Why?
Vascular Endothelial Growth Factor A
4
2017
189
0.240
Why?
Huntington Disease
1
2026
24
0.240
Why?
Mycoplasma genitalium
2
2018
2
0.230
Why?
Doxazosin
3
2015
3
0.230
Why?
Prevalence
7
2021
1034
0.230
Why?
Treatment Outcome
16
2020
5597
0.230
Why?
Mycoplasma Infections
2
2018
7
0.230
Why?
Doxycycline
3
2015
33
0.230
Why?
Cyclophosphamide
9
2021
178
0.230
Why?
Cancer Vaccines
1
2006
79
0.230
Why?
Anti-Infective Agents
2
2020
107
0.230
Why?
Vincristine
8
2021
89
0.220
Why?
Adolescent
13
2022
6912
0.220
Why?
Multicenter Studies as Topic
4
2024
114
0.220
Why?
Hematopoietic Stem Cell Transplantation
3
2018
610
0.220
Why?
Circadian Rhythm
1
2025
92
0.210
Why?
Air Filters
1
2024
1
0.210
Why?
Double-Blind Method
4
2013
729
0.210
Why?
CD4 Lymphocyte Count
7
2020
33
0.200
Why?
Bronchiolitis
1
2024
28
0.200
Why?
Air Pollution, Indoor
1
2024
27
0.200
Why?
5-alpha Reductase Inhibitors
2
2015
4
0.200
Why?
Hyperbaric Oxygenation
1
2023
15
0.200
Why?
Neoplasm Staging
5
2022
774
0.200
Why?
Cell Differentiation
3
2025
681
0.200
Why?
Substantia Nigra
1
2023
14
0.200
Why?
alpha-Synuclein
1
2023
11
0.200
Why?
Doxorubicin
8
2021
248
0.200
Why?
Cisplatin
3
2022
282
0.190
Why?
Tumor Necrosis Factor-alpha
2
2017
392
0.190
Why?
Transplantation Conditioning
2
2018
96
0.190
Why?
Informatics
1
2023
9
0.190
Why?
Herpesvirus 8, Human
5
2020
98
0.190
Why?
Prednisone
7
2021
101
0.190
Why?
Follow-Up Studies
8
2019
2318
0.190
Why?
Cross-Sectional Studies
3
2021
1723
0.190
Why?
Astrocytes
1
2024
139
0.190
Why?
Brachytherapy
1
2022
51
0.180
Why?
Neuroprotective Agents
2
2020
101
0.180
Why?
Watchful Waiting
1
2022
29
0.180
Why?
Medical Records
1
2022
85
0.180
Why?
Oxidative Phosphorylation
1
2022
48
0.180
Why?
Feasibility Studies
2
2021
412
0.180
Why?
Absorptiometry, Photon
1
2003
161
0.180
Why?
Substance Withdrawal Syndrome
1
2023
168
0.180
Why?
Brain Injuries
1
2023
160
0.180
Why?
Vitamin D Deficiency
1
2022
46
0.180
Why?
Vaccines
1
2022
49
0.180
Why?
Viral Load
6
2020
83
0.180
Why?
Child
7
2024
7384
0.180
Why?
Genome-Wide Association Study
3
2018
184
0.180
Why?
Case-Control Studies
3
2014
1212
0.170
Why?
Precancerous Conditions
1
2022
87
0.170
Why?
Clinical Trials as Topic
5
2020
466
0.170
Why?
Lymphocyte Activation
3
2017
163
0.170
Why?
Mouth Diseases
1
2021
5
0.170
Why?
Mass Screening
2
2015
362
0.170
Why?
Vaccination
3
2022
310
0.170
Why?
Thymus Gland
1
2021
39
0.170
Why?
Pluripotent Stem Cells
1
2021
8
0.170
Why?
Progestins
1
2020
10
0.170
Why?
T-Lymphocyte Subsets
2
2017
39
0.160
Why?
Physical Conditioning, Animal
1
2021
67
0.160
Why?
Drug Therapy, Combination
5
2015
405
0.160
Why?
Primary Health Care
2
2022
404
0.160
Why?
Vagina
2
2018
45
0.160
Why?
Etoposide
5
2021
71
0.160
Why?
Spleen
1
2021
166
0.160
Why?
Papillomavirus Vaccines
2
2013
74
0.160
Why?
Enzyme Inhibitors
2
2016
371
0.160
Why?
Anti-HIV Agents
3
2020
47
0.160
Why?
Cross-Over Studies
1
2021
241
0.160
Why?
Genes, myc
1
2020
39
0.160
Why?
Gene Frequency
2
2017
97
0.160
Why?
Overweight
1
2022
232
0.160
Why?
Transplantation, Autologous
3
2018
488
0.160
Why?
Aged, 80 and over
5
2013
3495
0.150
Why?
Nervous System Diseases
1
2020
93
0.150
Why?
Dihydroxyphenylalanine
1
2019
5
0.150
Why?
Dopaminergic Neurons
1
2019
19
0.150
Why?
Ablation Techniques
1
2019
19
0.150
Why?
Infant, Newborn
5
2024
2913
0.150
Why?
Genitalia, Male
1
2019
16
0.140
Why?
Altruism
1
2018
12
0.140
Why?
Sodium, Dietary
1
2019
24
0.140
Why?
Central Nervous System Diseases
1
2019
28
0.140
Why?
Mouth
1
2019
36
0.140
Why?
Asymptomatic Infections
1
2018
7
0.140
Why?
Dopamine
1
2019
167
0.140
Why?
Antiviral Agents
2
2013
179
0.140
Why?
Sexually Transmitted Diseases
1
2018
37
0.140
Why?
Encephalitis
1
2018
40
0.130
Why?
Hyperthermia, Induced
1
2019
114
0.130
Why?
Chlamydia
1
2017
8
0.130
Why?
Energy Metabolism
1
2020
324
0.130
Why?
Mucous Membrane
1
2017
32
0.130
Why?
Biopsy
2
2022
600
0.130
Why?
Regeneration
1
2018
83
0.130
Why?
Pilot Projects
3
2019
727
0.130
Why?
Blood Cells
1
2017
37
0.130
Why?
Genetic Predisposition to Disease
2
2018
533
0.130
Why?
Exosomes
1
2018
58
0.130
Why?
Protein Kinase Inhibitors
2
2023
234
0.130
Why?
DNA, Circular
1
2017
17
0.130
Why?
Clostridium Infections
1
2018
56
0.130
Why?
Antibodies, Bacterial
1
2017
29
0.130
Why?
Clonal Evolution
1
2017
59
0.120
Why?
Immunoglobulins
1
2017
76
0.120
Why?
Immunoglobulin G
1
2017
192
0.120
Why?
Enzyme-Linked Immunosorbent Assay
2
2017
233
0.120
Why?
Sentinel Lymph Node Biopsy
1
2017
119
0.120
Why?
Anus Diseases
1
2016
2
0.120
Why?
Telemedicine
1
2022
512
0.120
Why?
Lymph Node Excision
1
2017
132
0.120
Why?
Mannitol
1
2016
14
0.120
Why?
Guidelines as Topic
1
2016
111
0.120
Why?
Thiazoles
1
2016
52
0.120
Why?
Adrenergic alpha-1 Receptor Antagonists
1
2015
7
0.120
Why?
Diagnostic Self Evaluation
1
2015
13
0.120
Why?
Blood-Brain Barrier
1
2016
51
0.120
Why?
Dose-Response Relationship, Drug
4
2013
1367
0.110
Why?
CD4-Positive T-Lymphocytes
1
2017
166
0.110
Why?
T-Lymphocytes
1
2017
320
0.110
Why?
Educational Status
1
2016
229
0.110
Why?
Tinidazole
2
2012
2
0.110
Why?
Time Factors
6
2023
2992
0.110
Why?
Imidazoles
1
2016
114
0.110
Why?
Lymph Nodes
1
2017
252
0.110
Why?
Burkitt Lymphoma
1
2015
27
0.110
Why?
Drug Administration Schedule
5
2020
370
0.110
Why?
Menarche
1
2014
7
0.110
Why?
Data Collection
3
2023
288
0.110
Why?
Chromosomes, Human, Pair 2
1
2014
25
0.110
Why?
Obesity
3
2022
1205
0.110
Why?
Stomatitis
1
2014
19
0.110
Why?
Immunophenotyping
2
2017
118
0.110
Why?
Disease-Free Survival
5
2016
466
0.100
Why?
Carcinoma, Squamous Cell
1
2016
332
0.100
Why?
Benzamides
1
2013
52
0.100
Why?
Hypogonadism
1
2013
13
0.100
Why?
Incidence
4
2018
1085
0.100
Why?
Urban Population
1
2014
162
0.100
Why?
SEER Program
1
2013
106
0.100
Why?
Health Surveys
1
2014
248
0.100
Why?
Regenerative Medicine
2
2025
12
0.100
Why?
Organophosphonates
1
2013
6
0.100
Why?
Heart Failure
1
2019
531
0.100
Why?
DNA, Viral
3
2020
136
0.100
Why?
Perineum
1
2013
26
0.100
Why?
Testosterone
1
2013
142
0.100
Why?
Placebos
1
2013
80
0.100
Why?
Cytosine
1
2013
30
0.090
Why?
Adrenergic alpha-Antagonists
2
2009
27
0.090
Why?
Piperazines
1
2013
125
0.090
Why?
tau Proteins
1
2012
25
0.090
Why?
Prostate
2
2015
118
0.090
Why?
Trichomonas Infections
1
2012
2
0.090
Why?
Trichomonas vaginalis
1
2012
2
0.090
Why?
HIV
3
2023
26
0.090
Why?
Transforming Growth Factor beta1
1
2012
61
0.090
Why?
Pyrimidines
1
2013
206
0.090
Why?
Sleep
2
2024
196
0.090
Why?
Vulvar Neoplasms
1
2013
61
0.090
Why?
Medicare
1
2013
280
0.090
Why?
Urination Disorders
1
2011
23
0.090
Why?
Androgen Antagonists
1
2011
13
0.090
Why?
Comorbidity
1
2013
638
0.090
Why?
Sirolimus
1
2012
72
0.090
Why?
CD8-Positive T-Lymphocytes
2
2017
145
0.080
Why?
Antibiotics, Antineoplastic
1
2012
84
0.080
Why?
Kenya
2
2022
11
0.080
Why?
Quinazolinones
1
2011
7
0.080
Why?
Human papillomavirus 16
2
2013
44
0.080
Why?
Arkansas
1
2016
2068
0.080
Why?
Practice Guidelines as Topic
1
2013
502
0.080
Why?
Social Class
1
2011
97
0.080
Why?
Multivariate Analysis
1
2012
598
0.080
Why?
Prognosis
5
2017
2118
0.080
Why?
Chronic Disease
1
2012
581
0.080
Why?
Piperidines
1
2011
99
0.080
Why?
Plant Bark
1
2009
4
0.080
Why?
Multiple Myeloma
2
2014
3082
0.080
Why?
Valproic Acid
1
2009
35
0.080
Why?
Ki-67 Antigen
1
2009
57
0.070
Why?
Socioeconomic Factors
1
2012
623
0.070
Why?
Colorectal Neoplasms
1
2013
302
0.070
Why?
Logistic Models
1
2012
947
0.070
Why?
India
2
2021
59
0.070
Why?
Fruit
1
2009
129
0.070
Why?
Tetracyclines
2
2006
9
0.070
Why?
Neoplasm Recurrence, Local
1
2012
647
0.070
Why?
Survival Analysis
3
2017
659
0.070
Why?
Antiretroviral Therapy, Highly Active
3
2015
32
0.070
Why?
Adaptive Immunity
2
2017
32
0.070
Why?
Glioblastoma
1
2009
101
0.070
Why?
Chemoradiotherapy
2
2019
50
0.060
Why?
Sexual Partners
2
2018
45
0.060
Why?
Disease Progression
4
2013
880
0.060
Why?
Stress, Psychological
1
2009
283
0.060
Why?
Regression Analysis
2
2018
391
0.060
Why?
Chaperonins
1
2006
3
0.060
Why?
Chaperonin 60
1
2006
6
0.060
Why?
Dose-Response Relationship, Immunologic
1
2006
13
0.060
Why?
Lymphocyte Count
1
2006
20
0.060
Why?
Immunohistochemistry
3
2017
975
0.060
Why?
Papillomavirus E7 Proteins
1
2006
30
0.060
Why?
Viral Vaccines
1
2006
16
0.060
Why?
HIV Protease Inhibitors
1
2006
3
0.060
Why?
Sexual Behavior
2
2018
142
0.060
Why?
Coculture Techniques
1
2026
146
0.060
Why?
Interferon-alpha
1
2006
53
0.060
Why?
Infant
2
2024
3808
0.060
Why?
Nephrosis, Lipoid
1
2005
7
0.060
Why?
Arterioles
1
2005
32
0.060
Why?
Body Mass Index
2
2022
717
0.060
Why?
Recombinant Fusion Proteins
1
2006
175
0.060
Why?
Severity of Illness Index
2
2023
1049
0.060
Why?
Circadian Clocks
1
2025
3
0.060
Why?
Brain Neoplasms
1
2009
319
0.060
Why?
Matrix Metalloproteinase 9
3
2017
88
0.060
Why?
Administration, Oral
4
2013
456
0.060
Why?
Administration, Intranasal
1
2024
30
0.050
Why?
Phenotype
2
2017
803
0.050
Why?
Anti-Retroviral Agents
2
2019
18
0.050
Why?
Neutropenia
2
2020
113
0.050
Why?
Genotype
2
2017
563
0.050
Why?
Confidence Intervals
2
2015
158
0.050
Why?
Dust
1
2024
24
0.050
Why?
Particulate Matter
1
2024
66
0.050
Why?
Carbon
1
2024
60
0.050
Why?
Cytochrome P-450 CYP3A
1
2023
78
0.050
Why?
Neurons
1
2026
394
0.050
Why?
Femur Neck
1
2003
6
0.050
Why?
Bacterial Proteins
1
2006
349
0.050
Why?
Africa South of the Sahara
1
2022
6
0.050
Why?
Hip
1
2003
24
0.050
Why?
Oligomycins
1
2022
8
0.050
Why?
Rotenone
1
2022
13
0.050
Why?
Narcotics
1
2023
108
0.050
Why?
Galactose
1
2022
29
0.050
Why?
Quality Control
1
2003
98
0.050
Why?
Eating
1
2023
159
0.050
Why?
Sample Size
1
2022
50
0.050
Why?
Breast Feeding
1
2024
203
0.050
Why?
Femur
1
2003
133
0.050
Why?
Vitamins
1
2022
64
0.050
Why?
Spine
1
2003
87
0.050
Why?
Mice
2
2026
5982
0.040
Why?
Matrix Metalloproteinase Inhibitors
1
2002
9
0.040
Why?
Glycolysis
1
2022
76
0.040
Why?
Tetracycline
1
2002
24
0.040
Why?
Radiotherapy Dosage
1
2022
249
0.040
Why?
Vitamin D
1
2022
91
0.040
Why?
Sodium
1
2022
89
0.040
Why?
Tretinoin
1
2002
53
0.040
Why?
Leg
1
2022
123
0.040
Why?
Antibodies, Monoclonal
1
2005
477
0.040
Why?
Fibroblast Growth Factor 2
2
2017
35
0.040
Why?
Museums
1
2021
2
0.040
Why?
Alprostadil
1
2021
9
0.040
Why?
Ischemia
1
2022
158
0.040
Why?
Oxygen
1
2023
338
0.040
Why?
Progesterone
1
2020
57
0.040
Why?
Kidney
1
2005
717
0.040
Why?
Length of Stay
1
2024
684
0.040
Why?
Zimbabwe
1
2020
3
0.040
Why?
Receptors, Progesterone
1
2020
68
0.040
Why?
Software
1
2003
280
0.040
Why?
Malawi
1
2020
15
0.040
Why?
Wharton Jelly
1
2020
2
0.040
Why?
Uganda
1
2020
38
0.040
Why?
Spinal Cord Injuries
1
2020
56
0.040
Why?
Cell Shape
1
2020
21
0.040
Why?
Herpesvirus 4, Human
1
2020
44
0.040
Why?
Body Composition
1
2003
355
0.040
Why?
Glucose
1
2022
361
0.040
Why?
Neisseria gonorrhoeae
1
2020
4
0.040
Why?
Herpesviridae Infections
1
2020
57
0.040
Why?
Ceftriaxone
1
2020
24
0.040
Why?
Histone Deacetylase Inhibitors
1
2020
60
0.040
Why?
B-Lymphocytes
1
2021
178
0.040
Why?
Thrombocytopenia
1
2020
89
0.040
Why?
Drug Resistance, Bacterial
1
2020
80
0.040
Why?
Interleukin-6
2
2016
272
0.040
Why?
Remission Induction
2
2012
222
0.040
Why?
Proctoscopy
1
2019
2
0.040
Why?
Kaplan-Meier Estimate
1
2020
487
0.040
Why?
Microbial Sensitivity Tests
1
2020
276
0.040
Why?
Radiation-Sensitizing Agents
1
2019
50
0.040
Why?
Forelimb
1
2018
4
0.040
Why?
Cell Survival
1
2020
600
0.030
Why?
Green Fluorescent Proteins
1
2018
85
0.030
Why?
Rats, Inbred F344
1
2018
194
0.030
Why?
Statistics, Nonparametric
2
2013
198
0.030
Why?
Models, Animal
1
2019
233
0.030
Why?
Receptors, Chemokine
1
2017
12
0.030
Why?
Pandemics
1
2022
595
0.030
Why?
Cluster Analysis
1
2018
238
0.030
Why?
Coinfection
1
2018
41
0.030
Why?
Bone Marrow
1
2019
359
0.030
Why?
Neurodegenerative Diseases
1
2019
81
0.030
Why?
Postural Balance
1
2018
59
0.030
Why?
Neurogenesis
1
2017
29
0.030
Why?
Cell Separation
1
2017
76
0.030
Why?
Muscle Strength
1
2018
132
0.030
Why?
Cytological Techniques
1
2017
13
0.030
Why?
Interleukin-2
1
2017
69
0.030
Why?
Angiopoietin-1
1
2017
16
0.030
Why?
Receptor, TIE-2
1
2017
16
0.030
Why?
Axilla
1
2017
92
0.030
Why?
Angiopoietin-2
1
2017
17
0.030
Why?
Clinical Trials, Phase II as Topic
1
2017
48
0.030
Why?
Staining and Labeling
1
2017
94
0.030
Why?
Fluorouracil
1
2016
59
0.030
Why?
Gene Rearrangement
1
2017
76
0.030
Why?
Odds Ratio
1
2018
567
0.030
Why?
Biopsy, Needle
1
2017
181
0.030
Why?
Membrane Glycoproteins
1
2017
238
0.030
Why?
Interferon-gamma
1
2017
174
0.030
Why?
Mastectomy
1
2017
147
0.030
Why?
Cord Blood Stem Cell Transplantation
1
2016
9
0.030
Why?
Directly Observed Therapy
1
2015
5
0.030
Why?
Urine
1
2015
26
0.030
Why?
Reagent Kits, Diagnostic
1
2015
16
0.030
Why?
Neovascularization, Pathologic
1
2017
158
0.030
Why?
Vaginal Smears
1
2015
28
0.030
Why?
Flow Cytometry
1
2017
400
0.030
Why?
RNA, Viral
2
2009
123
0.030
Why?
Neoadjuvant Therapy
1
2017
124
0.030
Why?
Treatment Failure
1
2015
119
0.030
Why?
Prisons
1
2015
40
0.030
Why?
Ifosfamide
1
2015
9
0.030
Why?
Cytarabine
1
2015
44
0.030
Why?
Magnetic Resonance Imaging
1
2022
1587
0.030
Why?
Methotrexate
1
2015
78
0.030
Why?
Induction Chemotherapy
1
2014
65
0.030
Why?
Matrix Metalloproteinase 2
2
2006
58
0.030
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
19
0.030
Why?
Proto-Oncogene Proteins c-kit
1
2013
34
0.030
Why?
Cohort Studies
1
2018
1557
0.030
Why?
Depression
1
2019
621
0.020
Why?
Melphalan
1
2014
180
0.020
Why?
Statistics as Topic
1
2013
89
0.020
Why?
Gene Expression Regulation
1
2017
1003
0.020
Why?
Cancer Care Facilities
1
2013
20
0.020
Why?
Time
1
2013
28
0.020
Why?
Administration, Cutaneous
1
2013
53
0.020
Why?
Infusions, Intravenous
1
2013
211
0.020
Why?
Specialization
1
2013
48
0.020
Why?
Demography
1
2013
91
0.020
Why?
Molecular Targeted Therapy
1
2013
138
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2013
62
0.020
Why?
Combined Modality Therapy
1
2014
640
0.020
Why?
Antitrichomonal Agents
1
2012
1
0.020
Why?
Risk Assessment
1
2017
1368
0.020
Why?
Reference Values
1
2013
311
0.020
Why?
Polyethylene Glycols
1
2012
95
0.020
Why?
Medical Oncology
1
2013
97
0.020
Why?
Antigens, Viral
1
2012
44
0.020
Why?
Administration, Topical
1
2011
62
0.020
Why?
Single-Blind Method
1
2011
120
0.020
Why?
Neoplasm Proteins
1
2013
330
0.020
Why?
Organ Size
1
2011
228
0.020
Why?
Sex Factors
1
2013
747
0.020
Why?
Retrospective Studies
1
2022
6821
0.020
Why?
Survival Rate
1
2012
949
0.020
Why?
Antibodies, Viral
1
2010
109
0.020
Why?
Psychiatric Status Rating Scales
1
2009
325
0.020
Why?
Mutation
1
2013
1338
0.020
Why?
Busulfan
1
2008
18
0.020
Why?
Psychometrics
1
2009
244
0.020
Why?
Ultrasonography
1
2008
426
0.020
Why?
Maximum Tolerated Dose
1
2006
42
0.010
Why?
Injections, Subcutaneous
1
2006
55
0.010
Why?
Hypertension, Renal
1
2005
21
0.010
Why?
Cell Proliferation
1
2009
1031
0.010
Why?
Fatigue
1
2006
127
0.010
Why?
Recombinant Proteins
1
2006
489
0.010
Why?
Receptors, Interleukin-6
1
2002
22
0.010
Why?
Endothelial Growth Factors
1
2002
11
0.010
Why?
Vascular Endothelial Growth Factors
1
2002
15
0.010
Why?
Lymphokines
1
2002
20
0.010
Why?
Drug Tolerance
1
2002
60
0.010
Why?
Safety
1
2002
78
0.010
Why?
Child, Preschool
1
2005
4164
0.010
Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description